ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors - Wikidata - wikimedia - TriplyDB

ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors

ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors

http://www.wikidata.org/entity/Q28203390

about

sameAs

The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family The periovulatory period in cattle: progesterone, prostaglandins, oxytocin and ADAMTS proteases Aggrecanases and cartilage matrix degradation Tissue inhibitors of metalloproteinases Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration The metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways.ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome Discovery and characterization of a novel, widely expressed metalloprotease, ADAMTS10, and its proteolytic activation Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis ADAMTS7B, the full-length product of the ADAMTS7 gene, is a chondroitin sulfate proteoglycan containing a mucin domain Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1 Adamts-1 is essential for the development and function of the urogenital system Identification and characterization of ADAMTS-20 defines a novel subfamily of metalloproteinases-disintegrins with multiple thrombospondin-1 repeats and a unique GON domain Biosynthesis and expression of a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats-15: a novel versican-cleaving proteoglycanase The ADAMTS metalloproteinases Age-related changes in the proteoglycans of human skin. Specific cleavage of decorin to yield a major catabolic fragment in adult skin.ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2.Progress in matrix metalloproteinase research.PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'.ADAM and ADAMTS family proteins and their role in the colorectal cancer etiopathogenesis.Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1 Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.Determinants of versican-V1 proteoglycan processing by the metalloproteinase ADAMTS5 ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications Regulation of thrombospondin1 by extracellular proteases.Transcriptome-wide analysis of messenger RNA decay in normal and osteoarthritic human articular chondrocytes Metalloproteinases: their role in arthritis and potential as therapeutic targets.ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2 Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.The ADAMTS1 protease gene is required for mammary tumor growth and metastasis.Endothelial cells express a unique transcriptional profile under very high wall shear stress known to induce expansive arterial remodeling Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury.Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.Adamts1 mediates ethanol-induced alterations in collagen and elastin via a FoxO1-sestrin3-AMPK signaling cascade in myocytes.ADAMTS13 and 15 are not regulated by the full length and N-terminal domain forms of TIMP-1, -2, -3 and -4.Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

P2860

Q21146633-1E7CF5F1-1EDE-4544-B470-47067B9524B0 Q24597933-AAE33B4B-AD0E-4B24-B2C9-9EB4D74F32D3 Q24804310-9DBDC1C7-7193-4704-9D2C-7588A2F7EA89 Q26829539-5D95FF2E-DCEE-4AAA-9264-C335162BE02F Q27009408-C782DD56-C3EF-47BA-BD4B-DF2196C713A1 Q27687896-F24D4A6D-8AFA-465E-868D-C7F694686592 Q28271466-E1F029E3-96D8-41F4-A8B2-00CCF6CD1A2D Q28277874-04A5B219-08EC-49C6-885F-5F48DE5FB0A3 Q28280996-4685C2EF-4A47-422E-83B3-F9FB330F9497 Q28511878-3EBC3CAA-A39B-4444-B6DC-A217416B3F9E Q28512997-DD3961A0-9F58-40FC-B296-5DE5A2C2E4F1 Q28586832-87E63AD4-1352-4CFD-B056-90EA7312636F Q28588557-84BA2604-E986-4DC7-AD0C-CD037A478260 Q28591587-B8756AC8-0F13-4FF1-8D70-F8F3E763E6E8 Q28594757-B77B1CC0-8053-44D3-B2AA-46081E7AE211 Q29544428-91466272-D1D4-4214-AC61-3545100094B2 Q31134336-9EFC2258-0088-4D35-87E9-6D84B2294DF0 Q33241217-61A979BE-11D0-4B1A-AA26-2BFE8A6FC041 Q33608536-4C34C421-5F14-45A7-9387-57A2BCBD4945 Q33692377-5DD353EF-4516-4EBE-A460-58323AF7AF00 Q33808240-395E52AA-5D8D-4514-BDFB-2F94EA446599 Q34049378-B79D9127-D739-41CD-9072-6C5D95B58D2A Q34100940-9D4364A4-66BE-46D7-99B0-73CB6AAD7478 Q34108282-40DF696C-4040-4D00-9818-E0920FB01C23 Q34205901-389C82C8-9B56-4C07-8C19-D4C037BC3E53 Q34283551-F1E47BF7-A483-4CAF-AB2D-B51A8F8A58BE Q34287261-EE58FDC8-EBE2-4F72-A798-5987058AEAC5 Q34412131-0C724F4D-C55E-41FB-B13E-0E839A360AB2 Q34441372-4CD8E6C7-E51F-4245-86B0-7E4B0E46785C Q34521922-4C8E706F-CD00-4F9D-B560-6371ECA7CEF5 Q35056019-23F20C82-E40C-446C-B92F-AF4E577C45C1 Q35130971-F11ADD61-0A71-423A-ABE4-467A16446516 Q35605620-864CAD27-5E44-4AD5-8243-F281B40380CD Q35679442-ADD7D390-9C85-4CFC-8D80-E02609F2466D Q35900684-3E73E8A4-D30E-4F98-9E9E-5D08A8F51C1A Q35917508-AF3BCB7E-FBE8-4B92-BD82-85A99D827CEE Q36009930-A24C4444-1F31-41EA-9643-E51DD0969121 Q36478984-38179DE1-0C44-4754-AFBF-F3E4C00CD27A Q36502133-2BCBCED1-959E-464B-A517-77CB67F8570D Q36644577-43891D0D-E928-4332-872D-C18CE4E52DEA

P2860

ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors

http://www.wikidata.org/entity/Q28203390

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors

@ast

ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors

@en

ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors

@nl

type

label

ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors

@ast

ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors

@en

ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors

@nl

prefLabel

ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors

@ast

ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors

@en

ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors

@nl

P1433

Q28203390-A96C489F-5708-496B-A487-534B311C8EFD

P1476

Q28203390-A611BFF8-AAC9-4482-872C-1B92D15C1D67

P2093

Q28203390-2FD28310-C87B-47D6-AE0F-D1FAA915C153

Q28203390-35DF8C8E-5758-4BCB-8711-9245CBF4D286

Q28203390-578E92C8-1848-43D5-B9D9-9086DD3213CF

Q28203390-8A740B42-D608-4263-A2A5-2B7F2F4F5C10

Q28203390-A62461EB-08EF-45DC-A186-C488F8846C83

Q28203390-AA5A07F5-6151-4229-8C7A-F9E180E6FD8D

Q28203390-C5B1ED40-6D9C-4AB4-8BD2-3D90D3236908

P304

Q28203390-6FBF7694-F50C-47A2-BD6F-31E86DB60A76

P31

Q28203390-D5FFF9FC-F93E-47B6-9D15-99B85369BF85

P3181

Q28203390-3317CBE1-2DB7-4468-9883-0C7ED91E9C84

P356

Q28203390-17F7BD9C-231E-46BA-80DE-C9ED15EF96A4

P407

Q28203390-F1161DBF-E087-4EBB-B5A4-9DBD27E2CCC3

P433

Q28203390-25A87303-3B82-4888-99EB-5B5F4EE2DCBC

P478

Q28203390-1361CCBE-5F36-44F5-8441-40ED5FD44443

P50

Q28203390-6C84BA08-1661-46CA-BBF8-351ADB6AC499

P577

Q28203390-65F58284-0A8A-4F55-9DDD-B15B8526C2AD

P5875

Q28203390-0B146814-7ED2-4868-93D9-51E68F491FED

P698

Q28203390-E7040922-8514-4581-9F53-987070BF1805

P3181

P356

S0006-291X(02)00254-1

P1433

Biochemical and Biophysical Research Communications

P1476

ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors

@en

P2093

Alfonso Luque

http://www.w3.org/2001/XMLSchema#string

Gillian Murphy

http://www.w3.org/2001/XMLSchema#string

Jennifer Westling

http://www.w3.org/2001/XMLSchema#string

John D Sandy

http://www.w3.org/2001/XMLSchema#string

Juan Carlos Rodríguez-Manzaneque

http://www.w3.org/2001/XMLSchema#string

M Luisa Iruela-Arispe

http://www.w3.org/2001/XMLSchema#string

Shelley N-M Thai

http://www.w3.org/2001/XMLSchema#string

P304

501-508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4887686

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0006-291X(02)00254-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

293

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11318430

http://www.w3.org/2001/XMLSchema#string

P698

12054629

http://www.w3.org/2001/XMLSchema#string